Justia Products Liability Opinion Summaries
Cripe v. Henkel Corp.
While working on his employer’s roof, Cripe was exposed to fumes from PUR‐FECT LOK® 834A, a glue made by Henkel. and containing methylene diphenyl diisocyanate (MDI). Cripe claims that exposure to MDI caused him neurological and psychological problems, which could have been avoided by better warnings. The district court granted Henkel summary judgment, ruling that a toxic‐tort claim under Indiana law depends on expert proof of causation and that the Cripe had not produced such evidence. Cripe identified only one expert—Robinson, a specialist in the language of warnings, who disclaimed any opinion on causation. The Seventh Circuit affirmed. Cripe had not disclosed treating physicians as experts under FRCP 26(a)(2)(A). The fact that Robinson attached the physicians’ reports to her own did not indicate that they would function as experts. Rule 26(a)(2) requires more than disclosure of a potential expert’s name; documents attached to Robinson’s report did not contain any of the required information. Most of the physicians’ evaluations summarized Cripe’s symptoms and proposed treatment without discussing causation. None suggested a mechanism by which MDI would have caused the symptoms. By contrast, Henkel provided the district court with a comprehensive evaluation of MDI prepared by the World Health Organization. View "Cripe v. Henkel Corp." on Justia Law
Masephol v. Weyerhaeuser Co.
In 1952, the patent for a “Composite Fire Door,” issued to Owens‐Illinois. The patent claims never specifically mention asbestos, but describe a fire door with a “core of inorganic, rigid, fireproof, lightweight material of a substantially uniform apparent density and consistency throughout.” In 1956, Owens‐Illinois licensed the patent to Weyerhauser’s predecessor. Until 1978, its Marshfield, Wisconsin plant produced fire doors that used asbestos as a thermal insulator. The plaintiffs were all employees of that Marshfield plant and developed mesothelioma as a result of asbestos exposure. The Seventh Circuit affirmed the dismissal of their claims as covered by the exclusive remedy provisions of Wisconsin’s Worker’s Compensation Act, Wis. Stat. 102.03(2). The court rejected an attempt to avoid that bar by recharacterizing their injuries as occurring off the job based on a “public nuisance” theory involving ambient asbestos. The court characterized the claims against Owen‐Illinois claims as frivolous. View "Masephol v. Weyerhaeuser Co." on Justia Law
In Re: Zoloft t (Sertraline Hydrochloride) Products Liability Litigation
In multi-district litigation involving 315 product liability claims, plaintiffs alleged that Pfizer’s drug, Zoloft, a selective serotonin reuptake inhibitor (SSRI), caused cardiac birth defects. The Plaintiffs’ Steering Committee introduced several experts to establish causation. The testimony of each of these experts was excluded in whole or in part. In particular, Nicholas Jewell, Ph.D., a statistician, used the “Bradford Hill” criteria to analyze existing literature on the causal connection between Zoloft and birth defects. The district court conducted a Daubert hearing, excluded Jewell's testimony, and granted summary judgment to defendants, stating that Jewell: “failed to consistently apply the scientific methods he articulates, has deviated from or downplayed certain well-established principles of his field, and has inconsistently applied methods and standards to the data so as to support his a priori opinion.” The Third Circuit affirmed, holding that the district court did not require replication of significant results to establish reliability, but merely made a factual finding that teratologists generally require replication of significant results, and this factual finding did not prevent it from considering other evidence of reliability. View "In Re: Zoloft t (Sertraline Hydrochloride) Products Liability Litigation" on Justia Law
Miller v. Ford Motor Co.
The Ninth Circuit certified the following question to the Oregon Supreme Court: Oregon's statute of repose for products liability actions, Or. Rev. Stat. 30.905(2), provides that a civil action "must be commenced before the later of . . . ten years . . . or . . . the expiration of any statute of repose for an equivalent civil action in the state in which the product was manufactured . . . ." If the state of manufacture has no relevant statute of repose, is a plaintiff entitled to an unlimited period (subject to the statute of limitations) in which to bring suit in Oregon court? View "Miller v. Ford Motor Co." on Justia Law
Blaes v. Johnson & Johnson
Plaintiff filed a products liability action against defendants after his wife died of ovarian cancer. Plaintiff claimed that his wife's death was caused by her regular and prolonged use of talcum-based products. The Eighth Circuit held that the district court did not abuse its discretion when it dismissed the complaint without prejudice; the district court did not abuse its discretion by reasoning that it would be more efficient to add this case to another multi-plaintiff case with the same issues because the case would likely be tried at an earlier date in state court, and the dismissal would not prejudice defendants because plaintiff's case would be consolidated with a previously scheduled trial; the district court specifically addressed plaintiff's proposed reason for dismissing the action and implicitly rejected defendants' argument that plaintiff was forum shopping; defendants did not cite any support for their contention that a motion to dismiss should be denied only because defendants would be deprived of a federal forum; and the district court did not abuse its discretion by considering the information presented in plaintiff's reply brief. Accordingly, the court affirmed in part, reversed in part, and remanded to the district court to analyze whether costs and fees should be assessed and the amount, if any.
. View "Blaes v. Johnson & Johnson" on Justia Law
Graham v. R.J Reynolds Tobacco
Federal tobacco laws do not preempt state tort claims based on the dangerousness of all the cigarettes manufactured by the tobacco companies. The Florida Supreme Court upheld the jury verdicts of negligence and strict liability in Engle v. Liggett Group, Inc., 945 So. 2d 1246 (Fla. 2006) (Engle III), and decertified the class to allow individual actions about the remaining issues. In this case, R.J. Reynolds and Philip Morris challenged the jury verdict against them in one of the individual actions. The Eleventh Circuit affirmed its holding in Walker v. R.J. Reynolds Tobacco Co., 734 F.3d 1278 (11th Cir. 2013), and concluded that giving full faith and credit to the Engle jury findings of negligence and strict liability does not deprive R.J. Reynolds and Philip Morris of property without due process of law, and that federal law does not preempt the Engle jury findings. Accordingly, the court affirmed the judgments against R.J. Reynolds and Philip Morris. View "Graham v. R.J Reynolds Tobacco" on Justia Law
Donze v. General Motors
Comparative negligence does not apply in crashworthiness cases, and that South Carolina's public policy does not bar a plaintiff, allegedly intoxicated at the time of the accident, from bringing a crashworthiness claim against the vehicle manufacturer. This case concerned the applicability of comparative negligence to strict liability and breach of warranty claims in a crashworthiness case brought by Plaintiff Reid Donze against Defendant General Motors ("GM"). The United States District Court for the District of South Carolina certified two questions to the South Carolina Supreme Court Court addressing the defenses available to a manufacturer in crashworthiness cases brought under strict liability and breach of warranty theories. View "Donze v. General Motors" on Justia Law
Carlson v. Boston Scientific
The Fourth Circuit affirmed the MDL court's partial summary judgment award and denial of plaintiff's motion to reconsider. Plaintiff filed suit against Boston Scientific, alleging that the transvaginal mesh product that the company manufactured injured her and that Boston Scientific failed to warn of risks associated with the mesh. Plaintiff joined an MDL and then lost her failure to warn claim at summary judgment. After the case was transferred to a district court for trial on the remaining claims, plaintiff moved to reconsider the summary judgment award based on evidence that she failed to cite during summary judgment briefing in the MDL court. The district court denied the motion and plaintiff subsequently lost at trial. The Fourth Circuit could not say that the MDL court erred in its summary judgment ruling based on the evidence plaintiff cited in opposition to summary judgment. The Fourth Circuit explained that the Federal Rules of Civil Procedure require parties to cite all evidence in support of their positions at summary judgment. Finally, the district court did not abuse its discretion by denying the motion to reconsider despite plaintiff’s citation to additional excerpts of plaintiff's treating phsysician's deposition establishing that he reviewed and was familiar with the Directions for Use (DFU). View "Carlson v. Boston Scientific" on Justia Law
Cerveny v. Aventis, Inc.
The Cervenys sued the manufacturer of Clomid (Aventis, Inc.), asserting various tort claims under Utah law: failure to warn under theories of strict liability and negligence, breach of implied warranty, negligent misrepresentation, and fraud. They presented two theories, pointing to two types of warning labels that Aventis had allegedly failed to provide: (1) a label that warned of risks to the fetus when a woman takes Clomid before becoming pregnant; and (2) a label that unmistakably warned about harm to the fetus when Clomid is taken during pregnancy. The district court rejected the Cervenys’ claims based on preemption. The Tenth Circuit held that the district court ruling was correct on the Cervenys’ first theory, because the undisputed evidence showed that the FDA would not have approved a warning about taking Clomid before pregnancy. But on the second theory, the Tenth Circuit found the district court did not explain why a state claim based on the FDA’s own proposed language would be preempted by federal law. The district court also erred in failing to distinguish the remaining claims (breach of implied warranty, negligent misrepresentation, and fraud) from the failure-to-warn claims. These claims are based at least partly on affirmative misrepresentations rather than on a failure to provide a warning. The district court failed to explain why claims involving affirmative misrepresentations would have been preempted. View "Cerveny v. Aventis, Inc." on Justia Law
State v. Lacourse
Defendant was convicted of domestic violence assault, domestic violence stalking, and endangering the welfare of a child. The Supreme Judicial Court vacated the judgment of conviction as to the charge of domestic violence assault and remanded for entry of a judgment of acquittal on that charge, holding that the record contained insufficient evidence for the jury to find, beyond a reasonable doubt, that Defendant’s conduct forming that basis for domestic violence assault occurred within the relevant limitations period. The Court also remanded to determine whether resentencing was necessary as to the stalking and endangering the welfare of a child charges. View "State v. Lacourse" on Justia Law